Article (Scientific journals)
Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes
Pfleger, C.; Mortensen, H.B.; Hansen, L. et al.
2008In Diabetes, 57 (4), p. 929-937
Peer Reviewed verified by ORBi
 

Files


Full Text
pfleger et al. 2008.pdf
Publisher postprint (287.87 kB)
Download

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
diabetes; medical clinic; 610 medicine & health; IL-1ra; adiponectin; C-peptide; remission; patients; type 1 diabetes
Abstract :
[en] OBJECTIVE: We investigated the association of anti-inflammatory cytokine interleukin (IL)-1 receptor antagonist (IL-1ra), adiponectin, proinflammatory cytokines IL-1 beta, IL-6, and CCL2, and tumor necrosis factor-alpha with beta-cell function, metabolic status, and clinical remission in patients with recent-onset type 1 diabetes. RESEARCH DESIGN AND METHODS: Serum was obtained from 256 newly diagnosed patients (122 males and 134 females, median age 9.6 years). Stimulated C-peptide, blood glucose, and A1C were determined in addition to circulating concentration of cytokines at 1, 6, and 12 months after diagnosis. Analyses were adjusted for sex, age, and BMI percentile. RESULTS: Anti-inflammatory IL-1ra was positively associated with C-peptide after 6 (P = 0.0009) and 12 (P = 0.009) months. The beneficial association of IL-1ra on beta-cell function was complemented by the negative association of IL-1 beta with C-peptide after 1 month (P = 0.009). In contrast, anti-inflammatory adiponectin was elevated in patients with poor metabolic control after 6 and 12 months (P < 0.05) and positively correlated with A1C after 1 month (P = 0.0004). Proinflammatory IL-6 was elevated in patients with good metabolic control after 1 month (P = 0.009) and showed a positive association with blood glucose disposal after 12 months (P = 0.047). CONCLUSIONS: IL-1ra is associated with preserved beta-cell capacity in type 1 diabetes. This novel finding indicates that administration of IL-1ra, successfully improving beta-cell function in type 2 diabetes, may also be a new therapeutic approach in type 1 diabetes. The relation of adiponectin and IL-6 with remission and metabolic status transfers observations from in vitro and animal models into the human situation in vivo.
Disciplines :
Human health sciences: Multidisciplinary, general & others
Author, co-author :
Pfleger, C.
Mortensen, H.B.
Hansen, L.
Herder, C.
Roep, B.O.
Hoey, H.
Aanstoot, H.J.
Kocova, M.
Schloot, N.C.
Other collaborator :
De Beaufort, Carine ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
External co-authors :
yes
Language :
English
Title :
Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes
Publication date :
April 2008
Journal title :
Diabetes
ISSN :
1939-327X
Publisher :
American Diabetes Association, Alexandria, United States - Virginia
Volume :
57
Issue :
4
Pages :
929-937
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
THE HVIDØRE STUDY GROUP ON CHILDHOOD DIABETES
Available on ORBilu :
since 14 May 2016

Statistics


Number of views
35 (0 by Unilu)
Number of downloads
75 (0 by Unilu)

Scopus citations®
 
71
Scopus citations®
without self-citations
50
OpenCitations
 
65
WoS citations
 
65

Bibliography


Similar publications



Contact ORBilu